References
Albin, R. L., Young, A. B., & Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. Trends in neurosciences ,12 (10), 366-375.
Alexander, S. P., Battey, J., Benson, H. E., Benya, R.V., Bonner, T.I., Davenport, A.P., Dhanachandra. K. S., Eguchi, S., Harmar, A., Holliday, N., Jensen, R. T., Karnik, S., Kostenis, E., Liew, W. C., Monaghan, A. E., Mpamhanga, C., Neubig, R., Pawson, A.J., Pin, J. P., Sharman, J. L., Spedding, M., Spindel, E., Stoddart, L., Storjohann, L., Thomas, W. G., Tripula, K., & Vanderheyden, P. (2023). Class A Orphans in GtoPdb v.2023.1. IUPHAR/PBS Guide to Pharmacology. https://doi.org/10.2218/gtopdb/F16/2023.1 .
Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & Collaborators, C. (2017). THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors. Br J Pharmacol , 174 Suppl 1 (Suppl Suppl 1), S17-S129. https://doi.org/10.1111/bph.13878
Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & Collaborators, C. (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. Br J Pharmacol , 176 Suppl 1 (Suppl 1), S21-S141. https://doi.org/10.1111/bph.14748
Alkufri, F., Shaag, A., Abu-Libdeh, B., & Elpeleg, O. (2016). Deleterious mutation in GPR88 is associated with chorea, speech delay, and learning disabilities. Neurol Genet , 2 (3), e64. https://doi.org/10.1212/NXG.0000000000000064
Anton, R. F. (2008). Naltrexone for the management of alcohol dependence. New England Journal of Medicine , 359 (7), 715-721.
Batalla, A., Homberg, J. R., Lipina, T. V., Sescousse, G., Luijten, M., Ivanova, S. A., Schellekens, A. F. A., & Loonen, A. J. M. (2017). The role of the habenula in the transition from reward to misery in substance use and mood disorders. Neurosci Biobehav Rev ,80 , 276-285. https://doi.org/10.1016/j.neubiorev.2017.03.019
Ben Hamida, S., Carter, M., Darcq, E., Sourty, M., Rahman, M. T., Decker, A. M., Jin, C., & Kieffer, B. L. (2022). The GPR88 agonist RTI-13951-33 reduces alcohol drinking and seeking in mice. Addict Biol , 27 (6), e13227. https://doi.org/10.1111/adb.13227
Ben Hamida, S., Mendonca-Netto, S., Arefin, T. M., Nasseef, M. T., Boulos, L. J., McNicholas, M., Ehrlich, A. T., Clarke, E., Moquin, L., Gratton, A., Darcq, E., Harsan, L. A., Maldonado, R., & Kieffer, B. L. (2018). Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks. Biol Psychiatry ,84 (3), 202-212. https://doi.org/10.1016/j.biopsych.2018.01.026
Bianco, I. H., & Wilson, S. W. (2009). The habenular nuclei: a conserved asymmetric relay station in the vertebrate brain. Philos Trans R Soc Lond B Biol Sci , 364 (1519), 1005-1020. https://doi.org/10.1098/rstb.2008.0213
Bjarnadottir, T. K., Fredriksson, R., & Schioth, H. B. (2005). The gene repertoire and the common evolutionary history of glutamate, pheromone (V2R), taste(1) and other related G protein-coupled receptors.Gene , 362 , 70-84. https://doi.org/10.1016/j.gene.2005.07.029
Boden, J. M., & Fergusson, D. M. (2011). Alcohol and depression.Addiction , 106 (5), 906-914. https://doi.org/10.1111/j.1360-0443.2010.03351.x
Boulos, L. J., Darcq, E., & Kieffer, B. L. (2017). Translating the Habenula-From Rodents to Humans. Biol Psychiatry , 81 (4), 296-305. https://doi.org/10.1016/j.biopsych.2016.06.003
Brice, N. L., Schiffer, H. H., Monenschein, H., Mulligan, V. J., Page, K., Powell, J., Xu, X., Cheung, T., Burley, J. R., & Sun, H. (2021). Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease. Journal of Pharmacology and Experimental Therapeutics , 377 (3), 407-416.
Casadó, V., & Casadó-Anguera, V. (2023). What are the current trends in G protein-coupled receptor targeted drug discovery? In (pp. 1-6): Taylor & Francis.
Chang, J., Song, Z., Wei, S., Zhou, Y., Ju, J., Yao, P., Jiang, Y., Jin, H., Chi, X., & Li, N. (2023). Expression Mapping and Functional Analysis of Orphan G-Protein-Coupled Receptor GPR158 in the Adult Mouse Brain Using a GPR158 Transgenic Mouse. Biomolecules ,13 (3). https://doi.org/10.3390/biom13030479
Dandekar, M. P., Singru, P. S., Kokare, D. M., & Subhedar, N. K. (2008). Transient up-regulation of cocaine- and amphetamine-regulated transcript peptide (CART) immunoreactivity following ethanol withdrawal in rat hypothalamus. Brain Res , 1240 , 119-131. https://doi.org/10.1016/j.brainres.2008.09.023
Dayas, C. V., McGranahan, T. M., Martin-Fardon, R., & Weiss, F. (2008). Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol Psychiatry , 63 (2), 152-157. https://doi.org/10.1016/j.biopsych.2007.02.002
Dominguez, G. (2006). The CART gene: structure and regulation.Peptides , 27 (8), 1913-1918. https://doi.org/10.1016/j.peptides.2006.01.025
Douglass, J., & Daoud, S. (1996). Characterization of the human cDNA and genomic DNA encoding CART: a cocaine- and amphetamine-regulated transcript. Gene , 169 (2), 241-245. https://doi.org/10.1016/0378-1119(96)88651-3
Ehrlich, A. T., Maroteaux, G., Robe, A., Venteo, L., Nasseef, M. T., van Kempen, L. C., Mechawar, N., Turecki, G., Darcq, E., & Kieffer, B. L. (2018). Expression map of 78 brain-expressed mouse orphan GPCRs provides a translational resource for neuropsychiatric research.Communications Biology , 1 (1), 102.
Foster, S. R., Hauser, A. S., Vedel, L., Strachan, R. T., Huang, X. P., Gavin, A. C., Shah, S. D., Nayak, A. P., Haugaard-Kedstrom, L. M., Penn, R. B., Roth, B. L., Brauner-Osborne, H., & Gloriam, D. E. (2019). Discovery of Human Signaling Systems: Pairing Peptides to G Protein-Coupled Receptors. Cell , 179 (4), 895-908 e821. https://doi.org/10.1016/j.cell.2019.10.010
Fowler, C. D., & Kenny, P. J. (2012). Habenular signaling in nicotine reinforcement. Neuropsychopharmacology , 37 (1), 306-307. https://doi.org/10.1038/npp.2011.197
Fredriksson, R., Lagerstrom, M. C., Lundin, L. G., & Schioth, H. B. (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol , 63 (6), 1256-1272. https://doi.org/10.1124/mol.63.6.1256
Freitas-Lima, L. C., Pacesova, A., Stanurova, J., Sacha, P., Marek, A., Hubalek, M., Kunes, J., Zelezna, B., & Maletinska, L. (2023). GPR160 is not a receptor of anorexigenic cocaine- and amphetamine-regulated transcript peptide. Eur J Pharmacol , 949 , 175713. https://doi.org/10.1016/j.ejphar.2023.175713
Fricker, L. D., & Devi, L. A. (2018). Orphan neuropeptides and receptors: Novel therapeutic targets. Pharmacol Ther , 185 , 26-33. https://doi.org/10.1016/j.pharmthera.2017.11.006
Funayama, Y., Li, H., Ishimori, E., Kawatake-Kuno, A., Inaba, H., Yamagata, H., Seki, T., Nakagawa, S., Watanabe, Y., Murai, T., Oishi, N., & Uchida, S. (2023). Antidepressant Response and Stress Resilience Are Promoted by CART Peptides in GABAergic Neurons of the Anterior Cingulate Cortex. Biol Psychiatry Glob Open Sci , 3 (1), 87-98. https://doi.org/10.1016/j.bpsgos.2021.12.009
Ghate, A., Befort, K., Becker, J. A., Filliol, D., Bole-Feysot, C., Demebele, D., Jost, B., Koch, M., & Kieffer, B. L. (2007). Identification of novel striatal genes by expression profiling in adult mouse brain. Neuroscience , 146 (3), 1182-1192. https://doi.org/10.1016/j.neuroscience.2007.02.040
Gilpin, N. W., Herman, M. A., & Roberto, M. (2015). The central amygdala as an integrative hub for anxiety and alcohol use disorders.Biol Psychiatry , 77 (10), 859-869. https://doi.org/10.1016/j.biopsych.2014.09.008
Haddock, C. J., Almeida-Pereira, G., Stein, L. M., Hayes, M. R., Kolar, G. R., Samson, W. K., & Yosten, G. L. C. (2021). Signaling in rat brainstem via Gpr160 is required for the anorexigenic and antidipsogenic actions of cocaine- and amphetamine-regulated transcript peptide.Am J Physiol Regul Integr Comp Physiol , 320 (3), R236-R249. https://doi.org/10.1152/ajpregu.00096.2020
Hajj, M., De Vita, T., Vol, C., Renassia, C., Bologna, J. C., Brabet, I., Cazade, M., Pastore, M., Blahos, J., Labesse, G., Pin, J. P., & Prezeau, L. (2019). Nonclassical Ligand-Independent Regulation of Go Protein by an Orphan Class C G-Protein-Coupled Receptor. Mol Pharmacol , 96 (2), 233-246. https://doi.org/10.1124/mol.118.113019
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schioth, H. B., & Gloriam, D. E. (2017). Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov , 16 (12), 829-842. https://doi.org/10.1038/nrd.2017.178
Hauser, A. S., Chavali, S., Masuho, I., Jahn, L. J., Martemyanov, K. A., Gloriam, D. E., & Babu, M. M. (2018). Pharmacogenomics of GPCR Drug Targets. Cell , 172 (1-2), 41-54 e19. https://doi.org/10.1016/j.cell.2017.11.033
Hauser, A. S., Gloriam, D. E., Brauner-Osborne, H., & Foster, S. R. (2020). Novel approaches leading towards peptide GPCR de-orphanisation.Br J Pharmacol , 177 (5), 961-968. https://doi.org/10.1111/bph.14950
Heiber, M., Docherty, J. M., Shah, G., Nguyen, T., Cheng, R., Heng, H. H., Marchese, A., TSUI, L.-C., SHI, X., & GEORGE, S. R. (1995). Isolation of three novel human genes encoding G protein-coupled receptors. DNA and cell biology , 14 (1), 25-35.
Heiman, M., Schaefer, A., Gong, S., Peterson, J. D., Day, M., Ramsey, K. E., Suarez-Farinas, M., Schwarz, C., Stephan, D. A., & Surmeier, D. J. (2008). A translational profiling approach for the molecular characterization of CNS cell types. Cell , 135 (4), 738-748.
Ignatov, A., Lintzel, J., Kreienkamp, H. J., & Schaller, H. C. (2003). Sphingosine-1-phosphate is a high-affinity ligand for the G protein-coupled receptor GPR6 from mouse and induces intracellular Ca2+ release by activating the sphingosine-kinase pathway. Biochem Biophys Res Commun , 311 (2), 329-336. https://doi.org/10.1016/j.bbrc.2003.10.006
Jaworski, J. N., Hansen, S. T., Kuhar, M. J., & Mark, G. P. (2008). Injection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens reduces cocaine self-administration in rats. Behav Brain Res , 191 (2), 266-271. https://doi.org/10.1016/j.bbr.2008.03.039
Jeong, E., Kim, Y., Jeong, J., & Cho, Y. (2021). Structure of the class C orphan GPCR GPR158 in complex with RGS7-Gbeta5. Nat Commun ,12 (1), 6805. https://doi.org/10.1038/s41467-021-27147-1
Jin, C., Decker, A. M., Makhijani, V. H., Besheer, J., Darcq, E., Kieffer, B. L., & Maitra, R. (2018). Discovery of a Potent, Selective, and Brain-Penetrant Small Molecule that Activates the Orphan Receptor GPR88 and Reduces Alcohol Intake. J Med Chem , 61 (15), 6748-6758. https://doi.org/10.1021/acs.jmedchem.8b00566
Jones, P. G., Nawoschik, S. P., Sreekumar, K., Uveges, A. J., Tseng, E., Zhang, L., Johnson, J., He, L., Paulsen, J. E., & Bates, B. (2007). Tissue distribution and functional analyses of the constitutively active orphan G protein coupled receptors, GPR26 and GPR78. Biochimica et Biophysica Acta (BBA)-General Subjects , 1770 (6), 890-901.
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011). The efficacy of disulfiram for the treatment of alcohol use disorder. Alcoholism: Clinical and Experimental Research , 35 (10), 1749-1758.
Jung, S. K., Hong, M.-S., Suh, G.-J., Jin, S.-Y., Lee, H. J., Kim, B. S., Lim, Y. J., Kim, M. K., Park, H.-K., & Chung, J.-H. (2004). Association between polymorphism in intron 1 of cocaine-and amphetamine-regulated transcript gene with alcoholism, but not with bipolar disorder and schizophrenia in Korean population.Neuroscience letters , 365 (1), 54-57.
Kalivas, P. W., & Volkow, N. D. (2005). The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry ,162 (8), 1403-1413. https://doi.org/10.1176/appi.ajp.162.8.1403
Khrimian, L., Obri, A., Ramos-Brossier, M., Rousseaud, A., Moriceau, S., Nicot, A. S., Mera, P., Kosmidis, S., Karnavas, T., Saudou, F., Gao, X. B., Oury, F., Kandel, E., & Karsenty, G. (2017). Gpr158 mediates osteocalcin’s regulation of cognition. J Exp Med , 214 (10), 2859-2873. https://doi.org/10.1084/jem.20171320
King, B. J., Furlong, T. M., & McNally, G. P. (2010). Cocaine and amphetamine related transcript (CART) inhibits context induced reinstatement of reward seeking. Behav Neurosci , 124 (3), 423-427. https://doi.org/10.1037/a0019540
Kolb, P., Kenakin, T., Alexander, S. P. H., Bermudez, M., Bohn, L. M., Breinholt, C. S., Bouvier, M., Hill, S. J., Kostenis, E., Martemyanov, K. A., Neubig, R. R., Onaran, H. O., Rajagopal, S., Roth, B. L., Selent, J., Shukla, A. K., Sommer, M. E., & Gloriam, D. E. (2022). Community guidelines for GPCR ligand bias: IUPHAR review 32. Br J Pharmacol , 179 (14), 3651-3674. https://doi.org/10.1111/bph.15811
Kononoff, J., Kallupi, M., Kimbrough, A., Conlisk, D., de Guglielmo, G., & George, O. (2018). Systemic and Intra-Habenular Activation of the Orphan G Protein-Coupled Receptor GPR139 Decreases Compulsive-Like Alcohol Drinking and Hyperalgesia in Alcohol-Dependent Rats.eNeuro , 5 (3). https://doi.org/10.1523/ENEURO.0153-18.2018
Koylu, E. O., Couceyro, P. R., Lambert, P. D., & Kuhar, M. J. (1998). Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol ,391 (1), 115-132. https://www.ncbi.nlm.nih.gov/pubmed/9527537
Kranzler, H. R., & Soyka, M. (2018). Diagnosis and pharmacotherapy of alcohol use disorder: a review. Jama , 320 (8), 815-824.
Kreitzer, A. C., & Malenka, R. C. (2008). Striatal plasticity and basal ganglia circuit function. Neuron , 60 (4), 543-554.
Kuhar, M. J. (2016). CART Peptides and Drugs of Abuse: A Review of Recent Progress. J Drug Alcohol Res , 5 . https://doi.org/10.4303/jdar/235984
Kuhar, M. J., Adams, S., Dominguez, G., Jaworski, J., & Balkan, B. (2002). CART peptides. Neuropeptides , 36 (1), 1-8. https://doi.org/10.1054/npep.2002.0887
Laboute, T., Zucca, S., Holcomb, M., Patil, D. N., Garza, C., Wheatley, B. A., Roy, R. N., Forli, S., & Martemyanov, K. A. (2023). Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR.Science , 379 (6639), 1352-1358. https://doi.org/10.1126/science.add7150
Lakatos, A., Prinster, S., Vicentic, A., Hall, R. A., & Kuhar, M. J. (2005). Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors. Neurosci Lett , 384 (1-2), 198-202. https://doi.org/10.1016/j.neulet.2005.04.072
Lau, J., & Herzog, H. (2014). CART in the regulation of appetite and energy homeostasis. Front Neurosci , 8 , 313. https://doi.org/10.3389/fnins.2014.00313
Laun, A. S., Shrader, S. H., Brown, K. J., & Song, Z.-H. (2019). GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol. Acta Pharmacologica Sinica ,40 (3), 300-308.
Laun, A. S., & Song, Z.-H. (2017). GPR3 and GPR6, novel molecular targets for cannabidiol. Biochemical and biophysical research communications , 490 (1), 17-21.
Lee, D. K., George, S. R., O’Dowd, B. F., Evans, J. F., & Lynch, K. R. (2001). Orphan G protein-coupled receptors in the CNS. Current opinion in pharmacology , 1 (1), 31-39.
Li, J. X., Thorn, D. A., & Jin, C. (2013). The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats.Eur J Pharmacol , 698 (1-3), 272-277. https://doi.org/10.1016/j.ejphar.2012.10.037
Lin, Y., Hall, R. A., & Kuhar, M. J. (2011). CART peptide stimulation of G protein-mediated signaling in differentiated PC12 cells: identification of PACAP 6-38 as a CART receptor antagonist.Neuropeptides , 45 (5), 351-358. https://doi.org/10.1016/j.npep.2011.07.006
Liu, C., Bonaventure, P., Lee, G., Nepomuceno, D., Kuei, C., Wu, J., Li, Q., Joseph, V., Sutton, S. W., Eckert, W., Yao, X., Yieh, L., Dvorak, C., Carruthers, N., Coate, H., Yun, S., Dugovic, C., Harrington, A., & Lovenberg, T. W. (2015). GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids L-Tryptophan and L-Phenylalanine. Mol Pharmacol , 88 (5), 911-925. https://doi.org/10.1124/mol.115.100412
Lobo, M. K., Cui, Y., Ostlund, S. B., Balleine, B. W., & William Yang, X. (2007). Genetic control of instrumental conditioning by striatopallidal neuron–specific S1P receptor Gpr6. Nature neuroscience , 10 (11), 1395-1397.
Logue, S. F., Grauer, S. M., Paulsen, J., Graf, R., Taylor, N., Sung, M. A., Zhang, L., Hughes, Z., Pulito, V. L., Liu, F., Rosenzweig-Lipson, S., Brandon, N. J., Marquis, K. L., Bates, B., & Pausch, M. (2009). The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders? Mol Cell Neurosci , 42 (4), 438-447. https://doi.org/10.1016/j.mcn.2009.09.007
Maddern, X. J., Letherby, B., Ch’ng, S. S., Pearl, A., Gogos, A., Lawrence, A. J., & Walker, L. C. (2023). Cocaine and amphetamine regulated transcript (CART) mediates sex differences in binge drinking through central taste circuits. Neuropsychopharmacology . https://doi.org/10.1038/s41386-023-01712-2
Marchese, A., Cheng, R., Lee, M. C., Porter, C. A., Heiber, M., Goodman, M., George, S. R., & O’Dowd, B. F. (1994). Mapping studies of two G protein-coupled receptor genes: an amino acid difference may confer a functional variation between a human and rodent receptor. Biochem Biophys Res Commun , 205 (3), 1952-1958. https://doi.org/10.1006/bbrc.1994.2899
Margolin, D. H., Brice, N. L., Davidson, A. M., Matthews, K. L., & Carlton, M. B. (2022). A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson’s Disease. Journal of Pharmacology and Experimental Therapeutics , 381 (1), 33-41.
Maroteaux, G., Arefin, T. M., Harsan, L. A., Darcq, E., Ben Hamida, S., & Kieffer, B. L. (2018). Lack of anticipatory behavior in Gpr88 knockout mice showed by automatized home cage phenotyping. Genes Brain Behav , 17 (8), e12473. https://doi.org/10.1111/gbb.12473
Massart, R., Guilloux, J. P., Mignon, V., Sokoloff, P., & Diaz, J. (2009). Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents. Eur J Neurosci , 30 (3), 397-414. https://doi.org/10.1111/j.1460-9568.2009.06842.x
Matsuo, A., Matsumoto, S., Nagano, M., Masumoto, K. H., Takasaki, J., Matsumoto, M., Kobori, M., Katoh, M., & Shigeyoshi, Y. (2005). Molecular cloning and characterization of a novel Gq-coupled orphan receptor GPRg1 exclusively expressed in the central nervous system.Biochem Biophys Res Commun , 331 (1), 363-369. https://doi.org/10.1016/j.bbrc.2005.03.174
McLaughlin, I., Dani, J. A., & De Biasi, M. (2017). The medial habenula and interpeduncular nucleus circuitry is critical in addiction, anxiety, and mood regulation. J Neurochem , 142 Suppl 2 (Suppl 2), 130-143. https://doi.org/10.1111/jnc.14008
Meirsman, A. C., Ben Hamida, S., Clarke, E., de Kerchove d’Exaerde, A., Darcq, E., & Kieffer, B. L. (2019). GPR88 in D1R-Type and D2R-Type Medium Spiny Neurons Differentially Regulates Affective and Motor Behavior. eNeuro , 6 (4). https://doi.org/10.1523/ENEURO.0035-19.2019
Meirsman, A. C., Le Merrer, J., Pellissier, L. P., Diaz, J., Clesse, D., Kieffer, B. L., & Becker, J. A. (2016). Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist. Biol Psychiatry , 79 (11), 917-927. https://doi.org/10.1016/j.biopsych.2015.05.020
Meirsman, A. C., Robe, A., de Kerchove d’Exaerde, A., & Kieffer, B. L. (2016). GPR88 in A2AR Neurons Enhances Anxiety-Like Behaviors.eNeuro , 3 (4). https://doi.org/10.1523/ENEURO.0202-16.2016
Millan, E. Z., & McNally, G. P. (2012). Cocaine- and amphetamine-regulated transcript in the nucleus accumbens shell attenuates context-induced reinstatement of alcohol seeking. Behav Neurosci , 126 (5), 690-698. https://doi.org/10.1037/a0029953
Mizushima, K., Miyamoto, Y., Tsukahara, F., Hirai, M., Sakaki, Y., & Ito, T. (2000). A novel G-protein-coupled receptor gene expressed in striatum. Genomics , 69 (3), 314-321. https://doi.org/10.1006/geno.2000.6340
Mogi, C., Tomura, H., Tobo, M., Wang, J. Q., Damirin, A., Kon, J., Komachi, M., Hashimoto, K., Sato, K., & Okajima, F. (2005). Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. J Pharmacol Sci , 99 (2), 160-167. https://doi.org/10.1254/jphs.fp0050599
Munster, A., Sommer, S., Kukelova, D., Sigrist, H., Koros, E., Deiana, S., Klinder, K., Baader-Pagler, T., Mayer-Wrangowski, S., Ferger, B., Bretschneider, T., Pryce, C. R., Hauber, W., & von Heimendahl, M. (2022). Effects of GPR139 agonism on effort expenditure for food reward in rodent models: Evidence for pro-motivational actions.Neuropharmacology , 213 , 109078. https://doi.org/10.1016/j.neuropharm.2022.109078
Navandar, M., Martín-García, E., Maldonado, R., Lutz, B., Gerber, S., & Ruiz de Azua, I. (2021). Transcriptional signatures in prefrontal cortex confer vulnerability versus resilience to food and cocaine addiction-like behavior. Scientific Reports , 11 (1), 9076.
Nohr, A. C., Shehata, M. A., Hauser, A. S., Isberg, V., Mokrosinski, J., Andersen, K. B., Farooqi, I. S., Pedersen, D. S., Gloriam, D. E., & Brauner-Osborne, H. (2017). The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), alpha-, and beta-melanocyte stimulating hormone (alpha-MSH, and beta-MSH), and the conserved core motif HFRW. Neurochem Int ,102 , 105-113. https://doi.org/10.1016/j.neuint.2016.11.012
Nona, C. N., Hendershot, C. S., & Le Foll, B. (2019). Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research. Experimental and Clinical Psychopharmacology ,27 (4), 359.
Oeckl, P., Hengerer, B., & Ferger, B. (2014). G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson’s disease.Experimental neurology , 257 , 1-9.
Ong, Z. Y., & McNally, G. P. (2020). CART in energy balance and drug addiction: Current insights and mechanisms. Brain Res ,1740 , 146852. https://doi.org/10.1016/j.brainres.2020.146852
Orlandi, C., Xie, K., Masuho, I., Fajardo-Serrano, A., Lujan, R., & Martemyanov, K. A. (2015). Orphan Receptor GPR158 Is an Allosteric Modulator of RGS7 Catalytic Activity with an Essential Role in Dictating Its Expression and Localization in the Brain. J Biol Chem ,290 (22), 13622-13639. https://doi.org/10.1074/jbc.M115.645374
Pandey, S. C., Chartoff, E. H., Carlezon, W. A., Jr., Zou, J., Zhang, H., Kreibich, A. S., Blendy, J. A., & Crews, F. T. (2005). CREB gene transcription factors: role in molecular mechanisms of alcohol and drug addiction. Alcohol Clin Exp Res , 29 (2), 176-184. https://doi.org/10.1097/01.alc.0000153550.31168.1d
Patil, D. N., Singh, S., Laboute, T., Strutzenberg, T. S., Qiu, X., Wu, D., Novick, S. J., Robinson, C. V., Griffin, P. R., Hunt, J. F., Izard, T., Singh, A. K., & Martemyanov, K. A. (2022). Cryo-EM structure of human GPR158 receptor coupled to the RGS7-Gbeta5 signaling complex.Science , 375 (6576), 86-91. https://doi.org/10.1126/science.abl4732
Prud’homme, M., Cata, R., & Jutras-Aswad, D. (2015). Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence. Substance abuse: research and treatment , 9 , SART. S25081.
Quintana, A., Sanz, E., Wang, W., Storey, G. P., Guler, A. D., Wanat, M. J., Roller, B. A., La Torre, A., Amieux, P. S., McKnight, G. S., Bamford, N. S., & Palmiter, R. D. (2012). Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors.Nat Neurosci , 15 (11), 1547-1555. https://doi.org/10.1038/nn.3239
Rabiner, E. A., Uz, T., Mansur, A., Brown, T., Chen, G., Wu, J., Atienza, J., Schwarz, A. J., Yin, W., Lewis, Y., Searle, G. E., Dennison, J., Passchier, J., Gunn, R. N., & Tauscher, J. (2022). Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [(11)C]PHNO PET. Neuropsychopharmacology , 47 (7), 1405-1412. https://doi.org/10.1038/s41386-021-01204-1
Reichard, H. A., Schiffer, H. H., Monenschein, H., Atienza, J. M., Corbett, G., Skaggs, A. W., Collia, D. R., Ray, W. J., Serrats, J., Bliesath, J., Kaushal, N., Lam, B. P., Amador-Arjona, A., Rahbaek, L., McConn, D. J., Mulligan, V. J., Brice, N., Gaskin, P. L. R., Cilia, J., & Hitchcock, S. (2021). Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia. J Med Chem , 64 (15), 11527-11542. https://doi.org/10.1021/acs.jmedchem.1c00820
Rodriguez, F. D., Sanchez, M. L., & Covenas, R. (2023). Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment. Int J Mol Sci , 24 (10). https://doi.org/10.3390/ijms24108656
Roth, B. L., & Kroeze, W. K. (2015). Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily. J Biol Chem ,290 (32), 19471-19477. https://doi.org/10.1074/jbc.R115.654764
Salinas, A. G., Nguyen, C. T., Ahmadi-Tehrani, D., & Morrisett, R. A. (2014). Reduced ethanol consumption and preference in cocaine- and amphetamine-regulated transcript (CART) knockout mice. Addict Biol , 19 (2), 175-184. https://doi.org/10.1111/j.1369-1600.2012.00475.x
Schank, J. R. (2020). Neurokinin receptors in drug and alcohol addiction. Brain Res , 1734 , 146729. https://doi.org/10.1016/j.brainres.2020.146729
Shoblock, J. R., Welty, N., Fraser, I., Wyatt, R., Lord, B., Lovenberg, T., Liu, C., & Bonaventure, P. (2019). In vivo Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 Agonist. Front Pharmacol , 10 , 273. https://doi.org/10.3389/fphar.2019.00273
Shrader, S. H., & Song, Z.-H. (2020). Discovery of endogenous inverse agonists for G protein-coupled receptor 6. Biochemical and biophysical research communications , 522 (4), 1041-1045.
Sinha, R. (2012). How does stress lead to risk of alcohol relapse?Alcohol Res , 34 (4), 432-440. https://www.ncbi.nlm.nih.gov/pubmed/23584109
Somalwar, A. R., Choudhary, A. G., Sharma, P. R., B, N., Sagarkar, S., Sakharkar, A. J., Subhedar, N. K., & Kokare, D. M. (2018). Cocaine- and amphetamine-regulated transcript peptide (CART) induced reward behavior is mediated via G(i/o) dependent phosphorylation of PKA/ERK/CREB pathway. Behav Brain Res , 348 , 9-21. https://doi.org/10.1016/j.bbr.2018.03.035
Song, C., Orlandi, C., Sutton, L. P., & Martemyanov, K. A. (2019). The signaling proteins GPR158 and RGS7 modulate excitability of L2/3 pyramidal neurons and control A-type potassium channel in the prelimbic cortex. J Biol Chem , 294 (35), 13145-13157. https://doi.org/10.1074/jbc.RA119.007533
Song, Z., Young III, W. S., Brownstein, M. J., & Bonner, T. I. (1994). Molecular cloning of a novel candidate G protein-coupled receptor from rat brain. FEBS letters , 351 (3), 375-379.
Spanagel, R., Vengeliene, V., Jandeleit, B., Fischer, W. N., Grindstaff, K., Zhang, X., Gallop, M. A., Krstew, E. V., Lawrence, A. J., & Kiefer, F. (2014). Acamprosate produces its anti-relapse effects via calcium.Neuropsychopharmacology , 39 (4), 783-791. https://doi.org/10.1038/npp.2013.264
Spiess, J., Villarreal, J., & Vale, W. (1981). Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus.Biochemistry , 20 (7), 1982-1988. https://doi.org/10.1021/bi00510a038
Stoveken, H. M., Zucca, S., Masuho, I., Grill, B., & Martemyanov, K. A. (2020). The orphan receptor GPR139 signals via G(q/11) to oppose opioid effects. J Biol Chem , 295 (31), 10822-10830. https://doi.org/10.1074/jbc.AC120.014770
Susens, U., Hermans-Borgmeyer, I., Urny, J., & Schaller, H. C. (2006). Characterisation and differential expression of two very closely related G-protein-coupled receptors, GPR139 and GPR142, in mouse tissue and during mouse development. Neuropharmacology , 50 (4), 512-520. https://doi.org/10.1016/j.neuropharm.2005.11.003
Sutton, L. P., Orlandi, C., Song, C., Oh, W. C., Muntean, B. S., Xie, K., Filippini, A., Xie, X., Satterfield, R., Yaeger, J. D. W., Renner, K. J., Young, S. M., Jr., Xu, B., Kwon, H., & Martemyanov, K. A. (2018). Orphan receptor GPR158 controls stress-induced depression.Elife , 7 . https://doi.org/10.7554/eLife.33273
Takeda, S., Kadowaki, S., Haga, T., Takaesu, H., & Mitaku, S. (2002). Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett , 520 (1-3), 97-101. https://doi.org/10.1016/s0014-5793(02)02775-8
Tanaka, S., Ishii, K., Kasai, K., Yoon, S. O., & Saeki, Y. (2007). Neural expression of G protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP levels and promotes neurite outgrowth.Journal of Biological Chemistry , 282 (14), 10506-10515.
Tao, Y. X., & Conn, P. M. (2014). Chaperoning G Protein-Coupled Receptors: From Cell Biology to Therapeutics. Endocrine Reviews ,35 (4), 602-647. https://doi.org/10.1210/er.2013-1121
Uhlenbrock, K., Gassenhuber, H., & Kostenis, E. (2002). Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cellular signalling , 14 (11), 941-953.
Van Waes, V., Tseng, K. Y., & Steiner, H. (2011). GPR88 - a putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation. Basal Ganglia ,1 (2), 83-89. https://doi.org/10.1016/j.baga.2011.04.001
Vicentic, A., & Jones, D. C. (2007). The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction.J Pharmacol Exp Ther , 320 (2), 499-506. https://doi.org/10.1124/jpet.105.091512
Walker, L. C. (2021). A balancing act: the role of pro- and anti-stress peptides within the central amygdala in anxiety and alcohol use disorders. J Neurochem , 157 (5), 1615-1643. https://doi.org/10.1111/jnc.15301
Walker, L. C., Berizzi, A. E., Chen, N. A., Rueda, P., Perreau, V. M., Huckstep, K., Srisontiyakul, J., Govitrapong, P., Xiaojian, J., Lindsley, C. W., Jones, C. K., Riddy, D. M., Christopoulos, A., Langmead, C. J., & Lawrence, A. J. (2020). Acetylcholine Muscarinic M(4) Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents. Biol Psychiatry ,88 (12), 898-909. https://doi.org/10.1016/j.biopsych.2020.02.019
Walker, L. C., Hand, L. J., Letherby, B., Huckstep, K. L., Campbell, E. J., & Lawrence, A. J. (2021). Cocaine and amphetamine regulated transcript (CART) signalling in the central nucleus of the amygdala modulates stress-induced alcohol seeking.Neuropsychopharmacology , 46 (2), 325-333. https://doi.org/10.1038/s41386-020-00807-4
Walker, L. C., Huckstep, K. L., Becker, H. C., Langmead, C. J., & Lawrence, A. J. (2023). Targeting muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development. Br J Pharmacol . https://doi.org/10.1111/bph.16081
Walker, L. C., & Lawrence, A. J. (2018). Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders.Expert Opin Investig Drugs , 1-14. https://doi.org/10.1080/13543784.2018.1502269
Wang, J., Zhu, L. Y., Liu, Q., Hentzer, M., Smith, G. P., & Wang, M. W. (2015). High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139. Acta Pharmacol Sin ,36 (7), 874-878. https://doi.org/10.1038/aps.2015.12
Wang, L., Lee, G., Kuei, C., Yao, X., Harrington, A., Bonaventure, P., Lovenberg, T. W., & Liu, C. (2019). GPR139 and Dopamine D2 Receptor Co-express in the Same Cells of the Brain and May Functionally Interact.Front Neurosci , 13 , 281. https://doi.org/10.3389/fnins.2019.00281
Wang, L., Lee, G., Shih, A., Kuei, C., Nepomuceno, D., Wennerholm, M., Fan, F., Wu, J., Bonaventure, P., Lovenberg, T. W., & Liu, C. (2019). Mutagenesis of GPR139 reveals ways to create gain or loss of function receptors. Pharmacol Res Perspect , 7 (1), e00466. https://doi.org/10.1002/prp2.466
Wang, T., Zhou, G., He, M., Xu, Y., Rusyniak, W. G., Xu, Y., Ji, Y., Simon, R. P., Xiong, Z. G., & Zha, X. M. (2020). GPR68 Is a Neuroprotective Proton Receptor in Brain Ischemia. Stroke ,51 (12), 3690-3700. https://doi.org/10.1161/STROKEAHA.120.031479
Wei, S., Zheng, L., Chang, J., Jiang, J., Zhou, Z., Liao, H., Song, K., Liu, X., Chi, X., Li, H., Kuang, X., & Li, N. (2023). G protein-coupled receptor 158 modulates sensitivity to the sedative-hypnotic effect of ethanol in male mice. Alcohol Clin Exp Res (Hoboken) ,47 (7), 1261-1270. https://doi.org/10.1111/acer.15094
Witkiewitz, K., Saville, K., & Hamreus, K. (2012). Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility. Ther Clin Risk Manag , 8 , 45-53. https://doi.org/10.2147/TCRM.S23184
Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F., Nguyen, D. G., Caldwell, J. S., & Chen, Y. A. (2009). Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay.J Biol Chem , 284 (18), 12328-12338. https://doi.org/10.1074/jbc.M806516200
Yin, W., Han, D., Khudyakov, P., Behrje, R., Posener, J., Laurenza, A., & Arkilo, D. (2022). A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK-041 in healthy participants and patients with stable schizophrenia. Br J Clin Pharmacol ,88 (8), 3872-3882. https://doi.org/10.1111/bcp.15305
Yosten, G. L., Harada, C. M., Haddock, C., Giancotti, L. A., Kolar, G. R., Patel, R., Guo, C., Chen, Z., Zhang, J., Doyle, T. M., Dickenson, A. H., Samson, W. K., & Salvemini, D. (2020). GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents. J Clin Invest , 130 (5), 2587-2592. https://doi.org/10.1172/JCI133270
Zhang, L.-L., Wang, J.-J., Liu, Y., Lu, X.-B., Kuang, Y., Wan, Y.-H., Chen, Y., Yan, H.-M., Fei, J., & Wang, Z.-G. (2011). GPR26-deficient mice display increased anxiety-and depression-like behaviors accompanied by reduced phosphorylated cyclic AMP responsive element-binding protein level in central amygdala. Neuroscience , 196 , 203-214.